Study of Multiple Doses and Regimens of XL184 (Cabozantinib) in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Clinical Trial ID NCT01068782

PubWeight™ 3.30^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01068782

Top papers